Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123059912 | 12305991 | 2 | F | 2016 | 20160914 | 20160426 | 20160927 | PER | US-ASTRAZENECA-2016SE29018 | ASTRAZENECA | 982.00 | MON | F | Y | 76.20000 | KG | 20160927 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123059912 | 12305991 | 1 | SS | TENORMIN | ATENOLOL | 1 | Oral | 0 | 25 | MG | TABLET | QD | |||||||
| 123059912 | 12305991 | 2 | PS | BYDUREON | EXENATIDE | 1 | Subcutaneous | Y | U | 22200 | 2 | MG | /wk | ||||||
| 123059912 | 12305991 | 3 | SS | ZESTRIL | LISINOPRIL | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
| 123059912 | 12305991 | 4 | C | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | 0 | QD | ||||||||||
| 123059912 | 12305991 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 1000 | MG | BID | ||||||||
| 123059912 | 12305991 | 6 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | Oral | 0 | 2 | MG | QD | ||||||||
| 123059912 | 12305991 | 7 | C | HCTZ | HYDROCHLOROTHIAZIDE | 1 | Oral | 0 | 12.5 | MG | QD | ||||||||
| 123059912 | 12305991 | 8 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 0 | 112 | UG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123059912 | 12305991 | 1 | Blood pressure abnormal |
| 123059912 | 12305991 | 2 | Type 2 diabetes mellitus |
| 123059912 | 12305991 | 3 | Blood pressure abnormal |
| 123059912 | 12305991 | 4 | Type 2 diabetes mellitus |
| 123059912 | 12305991 | 5 | Type 2 diabetes mellitus |
| 123059912 | 12305991 | 6 | Type 2 diabetes mellitus |
| 123059912 | 12305991 | 7 | Blood pressure abnormal |
| 123059912 | 12305991 | 8 | Hypothyroidism |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123059912 | 12305991 | Blood glucose increased | |
| 123059912 | 12305991 | Urinary tract disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123059912 | 12305991 | 2 | 201602 | 0 | ||
| 123059912 | 12305991 | 4 | 201602 | 0 |